UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases Journal article
Cheang W.S., Fang X., Tian X.Y.. Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases[J]. Circulation Journal, 2013, 77(11), 2664-2671.
Authors:  Cheang W.S.;  Fang X.;  Tian X.Y.
Favorite | TC[WOS]:16 TC[Scopus]:16 | Submit date:2019/01/15
Atherosclerosis  Endothelial Function  Peroxisome Proliferator-activated Receptors  Vasculature  
Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors Journal article
Ouyang X., Chen X., Piatnitski E.L., Kiselyov A.S., He H.-Y., Mao Y., Pattaropong V., Yu Y., Kim K.H., Kincaid J., Smith II L., Wong W.C., Lee S.P., Milligan D.L., Malikzay A., Fleming J., Gerlak J., Deevi D., Doody J.F., Chiang H.-H., Patel S.N., Wang Y., Rolser R.L., Kussie P., Labelle M., Tuma M.C.. Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors[J]. Bioorganic and Medicinal Chemistry Letters, 2005, 15(23), 5154-5159.
Authors:  Ouyang X.;  Chen X.;  Piatnitski E.L.;  Kiselyov A.S.;  He H.-Y.; et al.
Favorite | TC[WOS]:66 TC[Scopus]:70 | Submit date:2019/01/16
1,2,4-triazole  Antimitotic  Tubulin Inhibitor  Tubulin Polymerization  Tumor Vasculature  Vascular Disrupting Agent